Boston Scientific and GE Healthcare today announced that the FDA has approved Boston Scientific’s LATITUDE 2.0 next-generation software with LATITUDE remote data integration capabilities—a remote monitoring system which will provide clinicians with direct device data integration capability into GE’s Centricity electronic medical record.
The enhanced version of the LATITUDE website also provides increased efficiencies to clinicians through streamlined system navigation, increased alert flexibility, faster printing and fine-tuned automatic scheduling. Remote home monitoring is an effective tool to help physicians manage patients with heart failure and other serious, chronic conditions as well as maintain a more thorough patient record.
“The collaboration between GE and Boston Scientific is a major stepping stone in our effort to provide a comprehensive patient record across the continuum of care,” said Vishal Wanchoo, president and CEO, GE Healthcare Integrated IT Solutions. “The ability to collect patient data remotely using LATITUDE technology and integrating that data, along with historical medical information, within the patient’s electronic medical record should empower physicians to make more accurate decisions at the point of care.”
“LATITUDE Integration further establishes Boston Scientific as the undisputed leader in remote patient management, and we are pleased to be the first company to reach this important milestone,” said Jim Tobin, president and chief executive officer, Boston Scientific. “We are also proud to be the first company to align with Heart Rhythm Society recommended guidelines for wireless device surveillance with what is fast becoming the standard of care.”
LATITUDE Patient Management is also the only wireless remote system directly aligned with the ACC/AHA physician society guidelines, which recommend monitoring weight, blood pressure, activity level and quality of life.